Postes actifs de Amira Barkal
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Pheast Therapeutics Inc
 Pheast Therapeutics Inc BiotechnologyHealth Technology Pheast Therapeutics Inc is a pre-clinical stage immuno-oncology company that focuses on targeting cancer immune evasion pathways to activate the innate immune system in the fight against cancer. The company is based in Palo Alto, CA. Pheast aims to develop novel therapies for some of the most difficult-to-treat and aggressive cancers, as well as women's cancers including ovarian cancer and breast cancer. The company was founded in 2020 and is led by scientific experts in innate immunity and cancer immunotherapy. Jacopo Leonardi has been the CEO of the company since 2023. | Corporate Officer/Principal | - | - |
| Fondateur | - | - | |
| Directeur Général | - | 05/01/2023 |
Historique de carrière de Amira Barkal
Statistiques
Internationale
| Etats-Unis | 2 |
Opérationnelle
| Chief Executive Officer | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Pheast Therapeutics Inc
Pheast Therapeutics Inc BiotechnologyHealth Technology Pheast Therapeutics Inc is a pre-clinical stage immuno-oncology company that focuses on targeting cancer immune evasion pathways to activate the innate immune system in the fight against cancer. The company is based in Palo Alto, CA. Pheast aims to develop novel therapies for some of the most difficult-to-treat and aggressive cancers, as well as women's cancers including ovarian cancer and breast cancer. The company was founded in 2020 and is led by scientific experts in innate immunity and cancer immunotherapy. Jacopo Leonardi has been the CEO of the company since 2023. | Health Technology |
- Bourse
- Insiders
- Amira Barkal
- Expérience
